FDA Inspection 1026870 — OMNILIFE USA, Inc. dba Texas OMNILIFE USA, Inc.
The FDA completed an inspection of OMNILIFE USA, Inc. dba Texas OMNILIFE USA, Inc. on September 8, 2017 in San Jose, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 8, 2017
- Fiscal Year
- 2017
- Product Type
- Food/Cosmetics
- Project Area
- Foodborne Biological Hazards
- Location
- San Jose, CA (United States)